Understanding the risk of NMS in young patients

Paul E. Croarkin, DO, MS, Editor-in-Chief, Journal of Child and Adolescent PsychopharmacologyNeuroleptic Malignant Syndrome is rare, serious, and previously understudied in children and adolescents. This important paper by Dr. Ray and colleagues has illuminated risk factors with immediate utility for clinical practice and provided a foundation for future research."

Source:

Mary Ann Liebert, Inc.

Journal references:

Ray, W. A., et al. (2024). Incidence of Neuroleptic Malignant Syndrome During Antipsychotic Treatment in Children and Youth: A National Cohort Study. Journal of Child and Adolescent Psychopharmacology. doi.org/10.1089/cap.2024.0047